Sort
48,018 grants matching “immunotherapy”
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2020 · AI
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2024 · AI
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2023 · AI
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$560,974Gerald V Denis · Boston University Medical Campus · U01 · FY2021 · CA
Kinetic Assembly of Polymer-mRNA Nanoparticles Targets Circulating Monocytes to Enhance Cancer Immunotherapy
$560,955Hai-Quan Mao · Johns Hopkins University · R01 · FY2023 · CA
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$560,920Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Balancing protective immunity and chronic sequelae by resident CD8 T cells
$560,876Jie Sun · Mayo Clinic Rochester · R01 · FY2021 · AI
TARGETING HEPATOCYTE-DERIVED FACTORS TO IMPROVE THE EFFICACY OF IMMUNOTHERAPY IN PANCREATIC CANCER
$560,870Trustees Of The University Of Pennsylvania, The · · FY2021 · Department of the Army
Escape from CAR T surveillance through lineage plasticity
$560,773Patricia A Ernst · University Of Colorado Denver · R01 · FY2023 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$560,724Dan R Littman · New York University School Of Medicine · R01 · FY2022 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$560,724Dan R Littman · New York University School Of Medicine · R01 · FY2023 · CA
Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment
$560,674Peixuan Guo · Ohio State University · U01 · FY2018 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$560,552Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$560,552Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
$560,469Harini Veeraraghavan · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Targeted therapy of B cell malignances with CAR-T cells of defined composition
$560,424Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Targeted therapy of B cell malignances with CAR-T cells of defined composition
$560,424Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Targeted therapy of B cell malignances with CAR-T cells of defined composition
$560,424Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Developmental Funds
$560,394Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2024 · CA
Linking Synucleinopathy and Dysfunction of Olfactory Pathways
$560,384Patrik Brundin · Van Andel Research Institute · R01 · FY2020 · DC
A deubiquitination module controls Treg adaptation to tumor microenvironment
$560,370Deyu Fang · Northwestern University At Chicago · R01 · FY2025 · CA
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$560,364David Reardon · Brigham And Women'S Hospital · P01 · FY2020 · CA
Immune cell control of ovarian cancer
$560,328Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis
$560,277Christine A Petersen · Ohio State University · R01 · FY2025 · AI
IMPACT OF INHIBITION OF KRAS/STK11-INDUCED IMMUNE SUPPRESSION IN ENHANCING IMMUNOTHERAPY RESPONSE
$560,262H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2015 · Department of Defense